-
Alcon Inc. (ALC $87.55)
- $87.55 Cap: $43.20B
- View ALC Profile
- View Questions on ALC
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Novo Nordisk A/S (NVO $64.88)
- $64.88 Fwd P/E: 18.14X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
-
Alcon Inc. (ALC $87.55)
- $87.55 Cap: $43.20B
- View ALC Profile
- View Questions on ALC
Q: I would like to increase my investments in foreign, but non-USA situs, companies, by buying ADRs (as my estate would be subject to US estate taxes). Currently, I have smallish positions in NVO (NovoNordisk; Danish) and ALC (Alcon; Swiss), which I am planning to add to. However, I would like to invest in up to three additional ADRs. My approach to investing (over the past 3 decades) is very long term buy & hold (indefinite holds, to bequeath to future generations), so I am aiming for high-quality companies. Can you perhaps provide your thoughts on NVO and ALC, as well as suggest up to 5 additional ADRs for consideration? (I'm not a fan of tobacco or gaming stocks, but generally open to wide spectrum of ideas.)
Ted
Ted
-
Alcon Inc. (ALC $87.55)
- $87.55 Cap: $43.20B
- View ALC Profile
- View Questions on ALC
-
Viatris Inc. (VTRS $8.95)
- $8.95 Cap: $10.42B
- View VTRS Profile
- View Questions on VTRS
Q: In your opinion, does Alcon and Viatris constitute a good buy at the moment?
Do they have growth potential?
Do they have growth potential?
Insiders
Share Information
SEC Filings
News and Media